Skip to main content
. 2009 Nov 25;108(2):363–368. doi: 10.1152/japplphysiol.00957.2009

Table 1.

Muscle free phenylalanine/leucine labeling in the final biopsy, the change in muscle protein bound phenylalanine/leucine labeling over time, and the duration between two biopsies or the time lapse from beginning the tracer infusion and the final biopsy for the single-biopsy approach

Two Biopsies
Single Biopsy
0 min and 210 min 60 min and 240 min “Zero” background Population average background
[ring-2H5]phenylalanine
    Muscle free TTR 0.0639 ± 0.0037 0.0642 ± 0.0078 0.0640 ± 0.0043 0.0640 ± 0.0043
    Time for FSR calculation, min 224 ± 4 171 ± 3 229 ± 3 229 ± 3
    ΔMuscle protein TTR 0.000119 ± 0.000022 0.000094 ± 0.000022 0.000147 ± 0.000021 0.000129 ± 0.000021
[5,5,5-2H3]leucine
    Muscle free TTR 0.0327 ± 0.0020 0.0530 ± 0.0078 0.0419 ± 0.0047 0.0419 ± 0.0047
    Time for FSR calculation, min 218 ± 3 177 ± 4 227 ± 4 227 ± 4
    ΔMuscle protein TTR 0.000046 ± 0.000005 0.000056 ± 0.000008 0.000107 ± 0.000023 0.000051 ± 0.000023

Values are means ± SE. TTR, tracer-to-tracee ratio; FSR, fractional synthesis rate.